The prognostic value of serum β 2 microglobulin compared with other presentation features in myelomatosis

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

Brian G.M. Durie, Sydney E. Salmon · Cancer · 1975 · 3.1K citations

Medicine, Hematology, Oncology +15

Immunological Identity of the Small Subunit of HL-A Antigens and β ₂ -Microglobulin and Its Turnover on the Cell Membrane

Peter Cresswell, Timothy A. Springer, Jack L. Strominger et al. · Proceedings of the National Academy of Sciences · 1974 · 204 citations · Full text

Life Sciences, Biochemistry, Immunology +6

Beta-2-microglobulin in myeloma: optimal use for staging, prognosis, and treatment--a prospective study of 160 patients

R Bataille, Jean‐Christophe Grenier, J Sany · Blood · 1984 · 180 citations · Full text

Medicine, Hematology, Oncology +10

Serum beta₂microglobulin and survival duration in multiple myeloma: a simple reliable marker for staging.

Régis Bataille, Brian G.M. Durie · British Journal of Haematology · 1983 · 178 citations

Medicine, Hematology, Oncology +8

β2-Microglobulin levels in cancerous and other disease states

J. Shuster, Phil Gold, M. D. Poulik · Clinica Chimica Acta · 1976 · 177 citations

Medicine, Biochemistry, Oncology +6